Explore EATRIS as a companya patienta scientista policy-makera visitor Login
ECaDE interview published online
Win a trip to Down Under including your ticket to AusBiotech 2018
CORBEL 2nd Open Call: Apply for Research Infrastructures Services
Transnational network for personalised medicine launches
EMA releases draft guideline on Safety and Efficacy (S&E) follow-up, and risk management for Advanced Therapy Medicinal Products (ATMPs).
EMA updates procedural advice to clarify regulatory process for Advanced Therapy Medicinal Products
ID-EPTRI: a new research infrastructure for better paediatric medicines emerges
2nd open call for RItrain knowledge exchange – profit from the expertise of other Research Infrastructures
New funding opportunity for neurodegenerative disease launched by NeurATRIS
Sweden begins the year by becoming a full member
Five reasons not to miss EMA’s Awareness Sessions, this March
National PET Center in Turku signs collaboration agreement to develop imaging for tissue fibrosis research, with help from EATRIS
Funding agency in the Netherlands supporting EATRIS
Funding agency in Latvia supporting EATRIS
Funding agency in Slovenia supporting EATRIS
Funding agency in Portugal supporting EATRIS
Funding agency in Luxembourg supporting EATRIS
Funding agency in Italy supporting EATRIS
